SCHEMBL31723170

SCHEMBL31723170

Cc1cccc2c(=O)c(C(=O)O)c(-c3cc(F)cc(F)c3)oc12

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.46
KMT2A Q03164 4/20 0.46
ALDH1A1 P00352 2/20 0.46
MAPT P10636 2/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
KDM4E B2RXH2 1/20 0.46
NPC1 O15118 1/20 0.46
HPGD P15428 1/20 0.46
HTT P42858 1/20 0.46
RAB9A P51151 1/20 0.46
MCL1 Q07820 1/20 0.45
TTR P02766 2/20 0.39
GLA P06280 2/20 0.37
ANO1 Q5XXA6 2/20 0.36
CYP1A1 P04798 1/20 0.35
CYP1A2 P05177 1/20 0.35
CYP1B1 Q16678 1/20 0.35
STING1 Q86WV6 1/20 0.35
GPR35 Q9HC97 1/20 0.35
NR4A1 P22736 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20918209 1.00 MEN1 (0.46) MEN1KMT2AALDH1A1MAPTSMN1; SMN2
SCHEMBL31723178 0.91 MEN1 (0.48) MEN1KMT2AALDH1A1MAPTSMN1; SMN2
SCHEMBL28895627 0.91 MEN1 (0.48) MEN1KMT2AALDH1A1MAPTSMN1; SMN2
SCHEMBL28824884 0.89 MEN1 (0.47) MEN1KMT2AALDH1A1MAPTSMN1; SMN2
SCHEMBL14266219 0.85 ALDH1A1 (0.58) MEN1KMT2AALDH1A1MAPTSMN1; SMN2
SCHEMBL20918211 0.85 MCL1 (0.46) MEN1KMT2AALDH1A1MAPTSMN1; SMN2
SCHEMBL31723134 0.85 MCL1 (0.46) MEN1KMT2AALDH1A1MAPTSMN1; SMN2
SCHEMBL20918264 0.84 KDM4E (0.56) MEN1KMT2AALDH1A1MAPTSMN1; SMN2
SCHEMBL31723147 0.84 KDM4E (0.56) MEN1KMT2AALDH1A1MAPTSMN1; SMN2
SCHEMBL28436214 0.82 S1PR2 (0.42) MEN1KMT2AALDH1A1MAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3699174-B1 COMPOSITION FOR PREVENTING OR TREATING TNF-RELATED DISEASES, CONTAINING DERIVATIVE AS ACTIVE INGREDIENT, AND METHOD FOR INHIBITING TNF ACTIVITY BY USING SAME ILAB (KR) 2025-11-12 EP claimed